2,662 results on '"Pancreatic Ducts pathology"'
Search Results
2. Impact of pancreatic ductal occlusion on postoperative outcomes in pancreatic head cancer patients undergoing neoadjuvant therapy.
- Author
-
Hidaka Y, Tanoue S, Ayukawa T, Takumi K, Noguchi H, Higashi M, Idichi T, Kawasaki Y, Kurahara H, Mataki Y, Ohtsuka T, and Koriyama C
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Retrospective Studies, Postoperative Complications epidemiology, Postoperative Complications etiology, Body Composition, Treatment Outcome, Pancreatic Neoplasms surgery, Pancreatic Neoplasms pathology, Neoadjuvant Therapy methods, Neoadjuvant Therapy adverse effects, Pancreaticoduodenectomy adverse effects, Nutritional Status, Exocrine Pancreatic Insufficiency etiology, Pancreatic Ducts pathology
- Abstract
Background: Pancreatic ductal occlusion can accompany pancreatic head cancer, leading to pancreatic exocrine insufficiency (PEI) and adverse effects on nutritional status and postoperative outcomes. We investigated its impact on nutritional status, body composition, and postoperative outcomes in patients with pancreatic head cancer undergoing neoadjuvant therapy (NAT)., Methods: We analyzed 136 patients with pancreatic head cancer who underwent NAT prior to intended pancreaticoduodenectomy (PD) between 2015 and 2022. Nutritional and anthropometric indices (body mass index [BMI], albumin, prognostic nutritional index [PNI], Glasgow prognostic score, psoas muscle index, subcutaneous adipose tissue index [SATI], and visceral adipose tissue index) and postoperative outcomes were compared between the occlusion (n = 78) and non-occlusion (n = 58) groups, in which 61 and 44 patients, respectively, ultimately underwent PD., Results: The occlusion group showed significantly lower post-NAT BMI, PNI, and SATI (p = 0.011, 0.005, and 0.015, respectively) in the PD cohort. The occlusion group showed significantly larger main pancreatic duct, smaller pancreatic parenchyma, and greater duct-parenchymal ratio (p < 0.001), and these morphological parameters significantly correlating with post-NAT nutritional and anthropometric indices. Postoperative 3-year survival and recurrence-free survival (RFS) rates were significantly poorer (p = 0.004 and 0.013) with pancreatic ductal occlusion, also identified as an independent postoperative risk factor for overall survival (hazard ratio [HR]: 2.31, 95% confidence interval [CI] 1.08-4.94, p = 0.030) and RFS (HR: 2.03, 95% CI 1.10-3.72, p = 0.023), in multivariate analysis., Conclusions: Pancreatic ductal occlusion may be linked to poorer postoperative outcomes due to PEI-related malnutrition., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
3. miR-605-3p may affect caerulein-induced ductal cell injury and pyroptosis in acute pancreatitis by targeting the DUOX2/NLRP3/NF-κB pathway.
- Author
-
Zhang G, Zhang Y, Wang B, Xu H, Xie D, and Guo Z
- Subjects
- Humans, Signal Transduction, Male, Cell Line, Pancreatic Ducts pathology, Pancreatic Ducts metabolism, Apoptosis, Female, Middle Aged, MicroRNAs genetics, MicroRNAs metabolism, Dual Oxidases metabolism, Dual Oxidases genetics, Pancreatitis pathology, Pancreatitis metabolism, Pancreatitis genetics, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, NLR Family, Pyrin Domain-Containing 3 Protein genetics, NF-kappa B metabolism, Ceruletide, Pyroptosis
- Abstract
Acute pancreatitis (AP) is a sudden-onset disease of the digestive system caused by abnormal activation of pancreatic enzymes. Dual oxidase 2 (DUOX2) has been found to be elevated in the progression of a variety of inflammatory diseases. Therefore, we analyzed the specific roles of DUOX2 in AP development. Blood samples were collected from of AP patients and healthy people, and the caerulein- stimulated human pancreatic duct cells (H6C7) were utilized to establish an AP cell model. Cell growth and apoptosis were measured using an MTT assay and TUNEL staining. Additionally, RT-qPCR and western blot assays were conducted to assess the RNA and protein expressions of the cells. ELISA kits were used to determine TNF-α, IL-6, IL-8, and IL-1β levels. The interaction between DUOX2 and miR-605-3p was predicted using the Targetscan database and confirmed by dual-luciferase report assay. We found that DUOX2 increased while miR-605-3p decreased in the blood of AP patients and caerulein-stimulated H6C7 cells. DUOX2 was targeted by miR-605-3p. Furthermore, DUOX2 knockdown or miR-605-3p overexpression promoted cell viability, decreased the TNF-α, IL-6, IL-8, and IL-1β levels, and inhibited apoptosis rate in caerulein-stimulated H6C7 cells. DUOX2 knockdown or miR-605-3p overexpression also increased the Bcl-2 protein levels and down-regulated Bax, cleaved-caspase-1, NLRP3 and p-p65. Interestingly, DUOX2 overexpression reversed the miR-605-3p mimic function in the caerulein-treated H6C7 cells. In conclusion, our research demonstrated that DUOX2 knockdown relieved the injury and inflammation in caerulein-stimulated H6C7 cells., Competing Interests: The authors declare there are no competing interests., (©2024 Zhang et al.)
- Published
- 2024
- Full Text
- View/download PDF
4. Main pancreatic duct involved IPMN without high-risk factors: how to judge the degree of malignancy based on MPD dilation?
- Author
-
Zhu Y, Mao Y, Wang J, Wang Z, and Chen X
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Risk Factors, ROC Curve, Retrospective Studies, CA-19-9 Antigen blood, Adult, Adenocarcinoma, Mucinous pathology, Aged, 80 and over, Pancreatic Ducts pathology, Pancreatic Ducts diagnostic imaging, Pancreatic Neoplasms pathology, Pancreatic Neoplasms diagnosis, Pancreatic Intraductal Neoplasms pathology, Carcinoma, Pancreatic Ductal pathology, Carcinoma, Pancreatic Ductal diagnosis
- Abstract
The aim of this study was to evaluate the cutoff value for identifying malignance in main pancreatic duct (MPD)-involved intraductal papillary mucinous neoplasm (IPMN) with an MPD diameter ranging from 5 to 10 mm. Clinical-radiological characteristics of 142 patients, including MPD-involved IPMNs (n = 53) and branch-duct (BD)-IPMNs (n = 89) were analyzed. Logistic regression analysis was used to determine the risk factors of malignant IPMNs and invasive carcinoma. ROC curves were used to identify different cutoffs in terms of preoperative MPD values to predict the presence of invasive carcinoma as well as malignant IPMNs, and the prediction performance was evaluated. For MPD-involved IPMNs (5 mm < MPD < 10 mm), MPD diameter of 7.5 mm for discriminating malignant IPMNs (area under curve [AUC] = 0.67) and 7.7 mm for discriminating invasive IPMNs (AUC = 0.56) were found to be the optimal cutoff values at receiver operating characteristic curve (ROC) analysis. MPD > 7.5 mm and carbohydrate antigen19-9 (Ca19-9) > 37 U/ml were found to be predictors of malignant IPMNs at univariate, and MPD > 7.5 mm was a predictor in multivariate analysis in MPD-involved IPMNs. The AUC of the ROC curve of MPD (7.5 mm) combined with Ca19-9 in identifying malignant IPMNs was 0.73 in MPD-involved IPMNs. MPD (7.5 mm) combined with Ca19-9 performed well in identifying malignant IPMNs in MPD-involved IPMNs., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
5. Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: still needed further discussion.
- Author
-
Wang F, Peng L, and Liu Y
- Subjects
- Humans, Reference Values, Age Factors, Middle Aged, Aged, Adult, Cholangiopancreatography, Magnetic Resonance, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Pancreatic Ducts anatomy & histology, Common Bile Duct diagnostic imaging, Common Bile Duct anatomy & histology, Common Bile Duct pathology
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2024
- Full Text
- View/download PDF
6. Diagnosis of pancreatic malignancies using an overnight-stored pancreatic juice cell block specimen.
- Author
-
Okuno M, Tanaka T, Iwata K, Mukai T, Watanabe N, Shimojo K, Iwasa Y, Tezuka R, Iwashita T, Tomita E, and Shimizu M
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Aged, Adult, Aged, 80 and over, Cytodiagnosis methods, Specimen Handling methods, Pancreatic Ducts pathology, Pancreatic Juice cytology, Pancreatic Neoplasms diagnosis, Pancreatic Neoplasms pathology, Sensitivity and Specificity
- Abstract
Background and Aims: Pancreatic juice cytology is useful for diagnosing pancreatic duct strictures and cystic lesions. However, some cases cannot be diagnosed using cytology. This study aimed to evaluate the utility of the overnight-stored pancreatic juice cell block (CB) method for diagnosing pancreatic disease., Methods: This retrospective study included 32 patients who presented with pancreatic duct strictures or cystic lesions between 2018 and 2024. The sensitivity, specificity, and accuracy of the CB method and single/multiple pancreatic juice cytology were compared to evaluate the utility of the CB., Result: An endoscopic nasopancreatic drainage tube was placed in the main pancreatic duct, and pancreatic juice was collected to create a CB specimen. The median amount of pancreatic juice collected was 180(30-200) mL, and the median number of cytological examinations was three(2-8). Of the 32 cases, 13 were malignant, and 19 were benign (non-malignant). The sensitivity was significantly higher for the CB method (62 %) than for single cytology(15 %, P = 0.0414), and there was no significant difference between CB and multiple cytology(54 %, P = 1.0). The specificity and accuracy were not significantly different between the CB method and single or multiple cytology. When multiple cytology and CB were combined, sensitivity improved to 77 %. The pathological findings of the CB specimens were similar to the surgical specimens, including immunohistochemistry., Conclusion: The overnight-stored pancreatic juice CB method was more effective than single cytology, with similar sensitivities to multiple cytology and can also be used for immunohistochemistry. The pancreatic juice CB method is useful for pancreatic juice assessment., (Copyright © 2024 IAP and EPC. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Photon-Counting CT Shows Side-Branch Intraductal Papillary Mucinous Neoplasm-Pancreatic Duct Connection.
- Author
-
Khanungwanitkul K and Schwartz FR
- Subjects
- Humans, Tomography, X-Ray Computed methods, Carcinoma, Pancreatic Ductal diagnostic imaging, Carcinoma, Pancreatic Ductal surgery, Male, Aged, Adenocarcinoma, Mucinous diagnostic imaging, Adenocarcinoma, Mucinous surgery, Adenocarcinoma, Mucinous pathology, Female, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms surgery
- Published
- 2024
- Full Text
- View/download PDF
8. Never discard enucleation as a possibility: successful enucleation of a neuroendocrine tumor in the pancreatic neck in long and close proximity to the main pancreatic duct.
- Author
-
Blanco N, Aliseda D, and Rotellar F
- Subjects
- Humans, Pancreatectomy methods, Neuroendocrine Tumors surgery, Neuroendocrine Tumors pathology, Pancreatic Ducts surgery, Pancreatic Ducts pathology, Pancreatic Neoplasms surgery, Pancreatic Neoplasms pathology
- Published
- 2024
- Full Text
- View/download PDF
9. A case of spontaneous acute obstructive suppurative pancreatic ductitis associated with intraductal papillary mucinous neoplasms.
- Author
-
Nakayama S, Fukuda A, Nishikawa S, Hirata A, Teramura M, Takai A, and Seno H
- Subjects
- Humans, Aged, Female, Pancreatitis complications, Carcinoma, Pancreatic Ductal complications, Carcinoma, Pancreatic Ductal diagnosis, Suppuration, Pancreatic Ducts pathology, Pancreatic Ducts diagnostic imaging, Cholangiopancreatography, Endoscopic Retrograde, Tomography, X-Ray Computed, Acute Disease, Pancreatic Intraductal Neoplasms complications, Anti-Bacterial Agents therapeutic use, Drainage, Pancreatic Neoplasms complications, Adenocarcinoma, Mucinous complications, Adenocarcinoma, Mucinous diagnosis
- Abstract
A 77-year-old woman was referred to our hospital due to left upper abdominal pain, appetite loss and body weight loss for 1 month. Her past medical history was diabetes and intraductal papillary mucinous neoplasms (IPMNs). She had no fever and physical examination revealed mild tenderness in the left upper abdomen. Blood tests showed elevated inflammatory response with normal serum pancreatic enzymes. Contrast-enhanced CT showed marked swelling of the pancreatic tail, increased peripancreatic fatty tissue density, multiple IPMNs and obscuration of the enlarged main pancreatic duct at the tail. EUS showed there was no obvious mass in the pancreas and protein plug was suspected in the main pancreatic duct. EUS-FNA was performed and pathology showed no malignancy. ERCP showed discharge of purulent pancreatic fluid from the major duodenal papilla and stenosis of the main pancreatic duct at the tail. The culture of the purulent pancreatic fluid revealed Streptococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa, leading to diagnosis of acute obstructive suppurative pancreatic ductitis (AOSPD). Endoscopic nasopancreatic drainage and antimicrobial treatment were started. The inflammatory response improved rapidly and the patient was discharged 30 days after admission. To our knowledge, this is the second reported case of spontaneous AOSPD associated with IPMNs., (© 2024. Japanese Society of Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
10. Unlooping the meandering main pancreatic duct in chronic pancreatitis.
- Author
-
Wang X, An J, and Pan Y
- Subjects
- Humans, Male, Middle Aged, Pancreatitis, Chronic diagnostic imaging, Pancreatitis, Chronic complications, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Pancreatic Ducts abnormalities, Cholangiopancreatography, Endoscopic Retrograde
- Abstract
Competing Interests: Disclosure All authors disclosed no financial relationships. Commentary Recurrent episodes of acute pancreatitis can be challenging to manage. Various risk factors for the development of idiopathic recurrent acute pancreatitis have been identified, including anatomic variants such as the presence of pancreas divisum. This report from Wang and colleagues demonstrates a less frequently encountered variant of pancreatic anatomy: the meandering main pancreatic duct. This variant can be a loop type, as in this case, or a hairpin type, also known as a Z-type configuration. The current case demonstrates a challenging scenario where the patient has chronic, calcific pancreatitis and stones in the main pancreatic duct. The loop-type main pancreatic duct made ductal clearing from stones difficult, but extraction was ultimately achieved after gentle manipulation of the duct into a more typical configuration with the extraction balloon. I particularly appreciate the high-quality pancreaticogram images demonstrating this technique. In addition to the occasional presence of meandering main pancreatic duct in patients with recurrent episodes of acute pancreatitis, readers should keep in mind that the condition may be associated with anomalous pancreaticobiliary junction and has been reported to occur in patients with choledochal cysts. Jordan Sparkman, MD, Assistant Professor of Medicine, Baylor College of Medicine, Houston, Texas, USA Amy Tyberg, MD, FASGE, FACG, Associate Editor for Focal Points
- Published
- 2024
- Full Text
- View/download PDF
11. Pancreatic Lipoma Penetrated by the Main Pancreatic Duct.
- Author
-
Matsubayashi H, Sato J, Ishiwatari H, and Ono H
- Subjects
- Humans, Male, Female, Middle Aged, Tomography, X-Ray Computed, Lipoma diagnostic imaging, Lipoma surgery, Lipoma diagnosis, Pancreatic Neoplasms diagnosis, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms surgery, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology
- Published
- 2024
- Full Text
- View/download PDF
12. Pancreatoscopy-Guided Endotherapies for Pancreatic Diseases.
- Author
-
Hanada Y and Shah RJ
- Subjects
- Humans, Endoscopy, Digestive System methods, Pancreatic Ducts surgery, Pancreatic Ducts pathology, Pancreatic Neoplasms therapy, Pancreatic Neoplasms surgery, Pancreatic Intraductal Neoplasms therapy, Pancreatic Intraductal Neoplasms surgery, Pancreatic Diseases therapy, Pancreatic Diseases surgery
- Abstract
Per-oral pancreatoscopy (POP) is a pancreas-preserving modality that allows for targeted pancreatic duct interventions, particularly in cases where standard techniques fail. POP specifically has an emerging role in the diagnosis, risk stratification, and disease extent determination of main duct intraductal papillary mucinous neoplasms (IPMNs). It has also been successfully used for laser ablation of IPMNs in poor surgical candidates, lithotripsy for complex stone disease, and laser stricturoplasty. As experience with POP increases beyond select referral center practices, further studies validating POP efficacy with long-term follow-up will help clarify when POP-guided intervention is most beneficial in relation to surgical intervention., Competing Interests: Disclosure Y. Hanada—None. R.J. Shah—Consultant for Boston Scientific, Olympus, and Dragonfly., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
13. Robotic Ultrasound-Guided Central Pancreatectomy with Main Pancreatic Duct Endoscopy Evaluation for High-Risk, Mixed-Type Intraductal Papillary Mucinous Neoplasm.
- Author
-
Giuliani G, Guerra F, Matarazzo F, De Franco L, Di Marino M, and Coratti A
- Subjects
- Humans, Male, Middle Aged, Pancreatic Intraductal Neoplasms surgery, Pancreatic Intraductal Neoplasms pathology, Pancreatic Intraductal Neoplasms diagnostic imaging, Carcinoma, Pancreatic Ductal surgery, Carcinoma, Pancreatic Ductal diagnostic imaging, Carcinoma, Pancreatic Ductal pathology, Adenocarcinoma, Mucinous surgery, Adenocarcinoma, Mucinous pathology, Adenocarcinoma, Mucinous diagnostic imaging, Prognosis, Pancreatectomy methods, Robotic Surgical Procedures methods, Pancreatic Ducts surgery, Pancreatic Ducts pathology, Pancreatic Ducts diagnostic imaging, Pancreatic Neoplasms surgery, Pancreatic Neoplasms pathology, Pancreatic Neoplasms diagnostic imaging
- Abstract
Background: Central pancreatectomy (CP) is a parenchymal-sparing technique indicated for the resection of selected lesions of the neck or proximal body of the pancreas.
1,2 The risk of postoperative complications is theoretically doubled because the surgeon has to manage two cut surfaces of the pancreas. The video shows a fully robotic CP to treat a 62-year-old male patient with a mixed-type intraductal papillary mucinous neoplasm (IPMN) of the pancreatic neck, using ultrasound (US) and Wirsung endoscopic evaluation to guide the pancreatic resection and ensure optimal resection margins., Materials and Methods: A US-guided robotic CP was carried out, and an intraoperative endoscopic evaluation of the MPD was performed to determine the distal transection level. A transmesocolic, end-to-side, robot-sewn Wirsung-jejunostomy with internal MPD stenting was then created. The procedure was completed with a side-to-side jejunojejunostomy., Results: The operative time was 290 min, with negligible blood loss. During the postoperative course, the patient experienced bleeding from a branch of the gastroduodenal artery with subsequent fluid collection, which was successfully treated with angioembolization and percutaneous drainage. He was discharged home on postoperative day 22. Final pathology revealed a non-invasive IPMN with low-grade dysplasia and free surgical margins. At 12 months of follow-up, the patient was doing well, with no evidence of local recurrence and endocrine or exocrine pancreatic insufficiency., Conclusions: The combination of robotic surgery with intraoperative US and Wirsungoscopy may offer distinct technical advantages for challenging pancreatectomies that follow the principles of parenchymal-sparing surgery., (© 2024. Society of Surgical Oncology.)- Published
- 2024
- Full Text
- View/download PDF
14. Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal Adenocarcinoma.
- Author
-
Kinny-Köster B, Ahmad Y, Pflüger MJ, Habib JR, Fujikura K, Hutchings D, Cameron JL, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, Javed AA, Yu J, Hruban RH, Wood LD, Thompson ED, and He J
- Subjects
- Humans, Male, Female, Retrospective Studies, Aged, Middle Aged, Neoplasm Recurrence, Local, Disease-Free Survival, Pancreatic Ducts pathology, Pancreatic Ducts surgery, Clinical Relevance, Carcinoma, Pancreatic Ductal surgery, Carcinoma, Pancreatic Ductal pathology, Carcinoma, Pancreatic Ductal mortality, Pancreatic Neoplasms surgery, Pancreatic Neoplasms pathology, Pancreatic Neoplasms mortality, Pancreatectomy methods
- Abstract
Objectives: Although prevalent in 50%-90% of pancreatic ductal adenocarcinomas, the clinical relevance of "cancerization of ducts" (COD) remains unknown., Methods: Pathologists retrospectively reviewed slides classifying prevalence of COD. Histopathological parameters, location of first recurrence, recurrence-free survival (RFS), and overall survival (OS) were collected from the institutional pancreatectomy registry., Results: Among 311 pancreatic ductal adenocarcinomas, COD was present in 216 (69.5%) and more prevalent in the cohort that underwent upfront surgery (75.3% vs 63.1%, P = 0.019). Furthermore, COD was associated with female gender (P = 0.040), advanced T stage (P = 0.007), perineural invasion (P = 0.014), lymphovascular invasion (P = 0.025), and R1 margin (P = 0.009), but not N stage (P = 0.401) or tumor differentiation (P = 0.717). In multivariable regression, COD was associated with less liver recurrence (odds ratio, 0.44; P < 0.005). This association was driven by the cohort of patients who had received preoperative treatment (odds ratio, 0.18; P < 0.001). COD was not predictive for RFS or OS., Conclusions: Cancerization of ducts was not associated with RFS or OS. Currently underrecognized, standardized implementation into histopathological reports may have merit, and further mechanistic scientific experiments need to illuminate its clinical and biologic impact., Competing Interests: The authors declare no conflict of interest., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
15. Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large-scale multicenter study.
- Author
-
Gonda M, Masuda A, Kobayashi T, Iemoto T, Kakuyama S, Ezaki T, Ikegawa T, Hirata Y, Tsumura H, Ogisu K, Nakano R, Fujigaki S, Nakagawa T, Takagi M, Yamanaka K, Sato Y, Fujita K, Furumatsu K, Kato T, Sakai A, Shiomi H, Sanuki T, Arisaka Y, Okabe Y, Toyama H, Sofue K, and Kodama Y
- Subjects
- Humans, Retrospective Studies, Male, Female, Middle Aged, Aged, Time Factors, Early Detection of Cancer methods, Dilatation, Pathologic diagnostic imaging, Pancreas diagnostic imaging, Pancreas pathology, Adult, Aged, 80 and over, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms pathology, Pancreatic Neoplasms diagnosis, Carcinoma, Pancreatic Ductal diagnostic imaging, Carcinoma, Pancreatic Ductal pathology, Disease Progression, Tomography, X-Ray Computed, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Atrophy
- Abstract
Background: Focal parenchymal atrophy and main pancreatic duct (MPD) dilatation have been identified as early signs of pancreatic ductal adenocarcinoma. However, limited evidence exists regarding their temporal progression due to previous study limitations with restricted case numbers., Objective: To ascertain a more precise frequency assessment of suspicious pancreatic ductal adenocarcinoma findings as well as delineate the temporal progression of them., Methods: A multicenter retrospective study was conducted on patients diagnosed with pancreatic ductal adenocarcinoma between 2015 and 2021. We included patients who had undergone at least one computed tomography (CT) scan ≥6 months before diagnosing pancreatic ductal adenocarcinoma. The temporal progression of suspicious pancreatic ductal adenocarcinoma findings on CT was investigated., Results: Out of 1832 patients diagnosed with pancreatic ductal adenocarcinoma, 320 had a previous CT before their diagnosis. Suspicious pancreatic ductal adenocarcinoma findings were detected in 153 cases (47.8%), with focal parenchymal atrophy (26.6%) being the most common followed by MPD dilatation (11.3%). Focal parenchymal atrophy was the earliest detectable sign among all suspicious findings and became visible on average 2.7 years before diagnosis, and the next most common, MPD dilatation, 1.1 years before diagnosis. Other findings, such as retention cysts, were less frequent and appeared around 1 year before diagnosis. Focal parenchymal atrophy followed by MPD dilatation was observed in 10 patients but not in reverse order. Focal parenchymal atrophy was more frequently detected in the pancreatic body/tail. No significant relationship was found between the pathological pancreatic ductal adenocarcinoma differentiation or tumor stage and the time course of the CT findings. All cases of focal parenchymal atrophy progressed just prior to diagnosis, and the atrophic area was occupied by tumor at diagnosis. Main pancreatic duct dilatation continued to progress until diagnosis., Conclusion: This large-scale study revealed that the temporal progression of focal parenchymal atrophy is the earliest detectable sign indicating pancreatic ductal adenocarcinoma. These results provide crucial insights for early pancreatic ductal adenocarcinoma detection., (© 2024 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
16. X-Box binding protein 1 downregulates SIRT6 to promote injury in pancreatic ductal epithelial cells.
- Author
-
Yang Z, Li S, Zhao C, Zhao Z, Tan J, Zhang L, and Huang Y
- Subjects
- Humans, Endoplasmic Reticulum Stress, Oxidative Stress, Cell Line, Ceruletide toxicity, Sirtuins metabolism, Sirtuins genetics, Epithelial Cells metabolism, X-Box Binding Protein 1 metabolism, X-Box Binding Protein 1 genetics, Apoptosis, Down-Regulation, Pancreatitis metabolism, Pancreatitis pathology, Pancreatic Ducts metabolism, Pancreatic Ducts pathology
- Abstract
Objective: Acute pancreatitis (AP) stands as a frequent cause for clinical emergency hospital admissions. The X-box binding protein 1 (XBP1) was found to be implicated in pancreatic acinar cell apoptosis. The objective is to unveil the potential mechanisms governed by XBP1 and SIRT6 in the context of AP., Methods: Caerulein-treated human pancreatic duct epithelial (HPDE) cells to establish an in vitro research model. The levels and regulatory role of SIRT6 in the treated cells were evaluated, including its effects on inflammatory responses, oxidative stress, apoptosis, and endoplasmic reticulum stress. The relationship between XBP1 and SIRT6 was explored by luciferase and ChIP experiments. Furthermore, the effect of XBP1 overexpression on the regulatory function of SIRT6 on cells was evaluated., Results: Caerulein promoted the decrease of SIRT6 and the increase of XBP1 in HPDE cells. Overexpression of SIRT6 slowed down the secretion of inflammatory factors, oxidative stress, apoptosis level, and endoplasmic reticulum stress in HPDE cells. However, XBP1 negatively regulated SIRT6, and XBP1 overexpression partially reversed the regulation of SIRT6 on the above aspects., Conclusion: Our study illuminates the role of XBP1 in downregulating SIRT6 in HPDE cells, thereby promoting cellular injury. Inhibiting XBP1 or augmenting SIRT6 levels holds promise in preserving cell function and represents a potential therapeutic avenue in the management of AP., (© 2024 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
17. Visibility and Size of the Pancreatic Duct and Common Bile Duct on Routine 2D MRI Sequences in Children Without Pancreaticobiliary Disease.
- Author
-
Kocaoglu M, Ata NKA, Smith EA, Towbin AJ, Debnath P, and Trout AT
- Subjects
- Humans, Female, Male, Child, Retrospective Studies, Adolescent, Child, Preschool, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Magnetic Resonance Imaging methods, Common Bile Duct diagnostic imaging
- Abstract
BACKGROUND. Pancreatic duct (PD) or common bile duct (CBD) dilatation can indicate ductal pathology, but limited data describe normal pediatric duct measurements on routine 2D MRI sequences. OBJECTIVE. The purpose of this study was to characterize the visibility and diameter of the PD and CBD on 2D MR images in children without pancreaticobiliary disease. METHODS. This retrospective study included patients who underwent abdominal MRI using a rapid protocol (composed of noncontrast axial and coronal 2D SSFSE sequences) to assess for suspected appendicitis or ovarian torsion in the emergency department setting between January 23, 2023, and September 13, 2023, and excluded patients with a pancreatic or hepatobiliary abnormality on MRI or laboratory assessment. Four pediatric radiologists independently reviewed examinations. Reviewers recorded PD visibility in each of four segments (i.e., head, neck, body, and tail) and CBD visibility, and reviewers measured PD diameter in each segment and maximal CBD diameter. Duct measurements by age were characterized by linear regression analyses. RESULTS. The study included 177 patients (112 female patients, 65 male patients; mean age, 12.3 ± 3.4 [SD] years [age range, 5.1-17.7 years]). The observers reported PD visibility in the head in 35.6-94.9% of patients, neck in 18.6-72.3%, body in 22.6-89.8%, and tail in 7.3-26.0% and reported PD visibility in all four segments in 6.2-22.6% of patients. Maximum PD diameter in any segment, as a mean across observers, was 1.8 mm (range across observers, 0.7-3.5 mm). The expected maximal PD diameter in any segment, in terms of the 5th and 95th percentile values of observers' mean measurements, was 1.4-2.3 mm; the prediction interval's upper limit increased from age 5 to age 17 from 2.1 to 2.5 mm. All observers reported CBD visibility in all patients. The mean CBD diameter across observers was 3.1 mm (range across observers, 2.9-3.4 mm). The expected CBD diameter, in terms of the 5th and 95th percentile values of observers' mean measurements, was 2.3-4.9 mm; the prediction interval's upper limit increased from age 5 to age 17 from 3.9 to 5.0 mm. CONCLUSION. We report expected upper limits for PD and CBD measurements on 2D MR images in children without evidence of pancreaticobiliary disease. CLINICAL IMPACT. These findings may aid radiologists' identification of pancreaticobiliary duct abnormalities on routine abdominal MRI examinations.
- Published
- 2024
- Full Text
- View/download PDF
18. Development of a novel CT-based index for predicting the number of extracorporeal shockwave lithotripsy (ESWL) sessions required for successful fragmentation of obstructing pancreatic duct stones.
- Author
-
Bush N, Chandragiri P, Gaurav NA, Sonaiya S, Lahooti I, Singh A, Gupta A, Afghani E, Papachristou G, Khashab MA, Lee PJ, Talukdar R, Lakhtakia S, Singh VK, Han S, Tandan M, and Akshintala VS
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Retrospective Studies, Treatment Outcome, Pancreatitis, Chronic therapy, Pancreatitis, Chronic complications, Pancreatitis, Chronic diagnostic imaging, Lithotripsy methods, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Tomography, X-Ray Computed, Calculi therapy, Calculi diagnostic imaging
- Abstract
Background & Aim: Extracorporeal shock wave lithotripsy (ESWL) is used for the treatment of pancreatic duct stones (PDS) in patients with chronic pancreatitis (CP). We aimed to develop a CT based index to predict the required number of ESWL sessions for technical success., Methods: We retrospectively evaluated patients with PDS secondary to CP who underwent ESWL. Technical success was defined as the complete fragmentation of stones to <3 mm. CT features including PDS size, number, location, and density in Hounsfield units (HU) were noted. We analyzed the relationship between PDS characteristics and the number of ESWL sessions required for technical success. A multiple linear regression model was used to combine size and density into the pancreatic duct stone (PDS) index that was translated into a web-based calculator., Results: There were 206 subjects (mean age 38.6 ± 13.7 years, 59.2% male) who underwent ESWL. PDS size showed a moderate correlation with the number of ESWL sessions (r = 0.42, p < 0.01). PDS in the head required a fewer number of sessions in comparison to those in the body (1.4 ± 0.6 vs. 1.6 ± 0.7, p = 0.01). There was a strong correlation between PDS density and the number of ESWL sessions (r = 0.617, p-value <0.01). The PDS index {0.3793 + [0.0009755 x PDS density (HU)] + [0.02549 x PDS size (mm)]} could accurately predict the required number of ESWL sessions with an AUC of 0.872 (p < 0.01)., Conclusion: The PDS index is a useful predictor of the number of ESWL sessions needed for technical success that can help in planning and patient counseling., (Copyright © 2024 IAP and EPC. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
19. Identifying predictors for comorbidities related mortality versus pancreatic cancer related mortality in patients with intraductal papillary mucinous neoplasm.
- Author
-
Sekine K, Nagata N, Hisada Y, Yamamoto K, Mukai S, Tsuchiya T, Machitori A, Kojima Y, Yada T, Yamamoto N, Uemura N, Itoi T, and Kawai T
- Subjects
- Humans, Male, Female, Aged, Retrospective Studies, Middle Aged, Risk Factors, Follow-Up Studies, Carcinoma, Pancreatic Ductal mortality, Carcinoma, Pancreatic Ductal complications, Carcinoma, Pancreatic Ductal pathology, Risk Assessment methods, Adenocarcinoma, Mucinous mortality, Adenocarcinoma, Mucinous pathology, Adenocarcinoma, Mucinous complications, Pancreatic Ducts pathology, Pancreatic Ducts diagnostic imaging, Aged, 80 and over, Comorbidity, Pancreatic Neoplasms mortality, Pancreatic Neoplasms pathology, Pancreatic Neoplasms complications, Pancreatic Neoplasms epidemiology, Pancreatic Intraductal Neoplasms mortality, Pancreatic Intraductal Neoplasms pathology, Pancreatic Intraductal Neoplasms epidemiology, Pancreatic Intraductal Neoplasms complications
- Abstract
Backgrounds: Few data are available for surveillance decisions focusing on factors related to mortality, as the primary outcome, in intraductal papillary mucinous neoplasm (IPMN) patients., Aims: We aimed to identify imaging features and patient backgrounds associated with mortality risks by comparing pancreatic cancer (PC) and comorbidities., Methods: We retrospectively conducted a multicenter long-term follow-up of 1864 IPMN patients. Competing risk analysis was performed for PC- and comorbidity-related mortality., Results: During the median follow-up period of 5.5 years, 14.0% (261/1864) of patients died. Main pancreatic duct ≥5 mm and mural nodules were significantly related to all-cause and PC-related mortality, whereas cyst ≥30 mm did not relate. In 1730 patients without high-risk imaging features, 48 and 180 patients died of PC and comorbidity. In the derivation cohort, a prediction model for comorbidity-related mortality was created, comprising age, cancer history, diabetes mellitus complications, chronic heart failure, stroke, paralysis, peripheral artery disease, liver cirrhosis, and collagen disease in multivariate analysis. If a patient had a 5 score, 5- and 10-year comorbidity-related mortality is estimated at 18.9% and 50.2%, respectively, more than 7 times higher than PC-related mortality. The model score was also significantly associated with comorbidity-related mortality in a validation cohort., Conclusions: This study demonstrates main pancreatic duct dilation and mural nodules indicate risk of PC-related mortality, identifying patients who need periodic examination. A comorbidity-related mortality prediction model based on the patient's age and comorbidities can stratify patients who do not require regular tests, especially beyond 5 years, among IPMN patients without high-risk features., Clinical Trial Registration: T2022-0046., (© 2024 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
20. Distinctive Pathology Associated With Focal Stenosis of the Main Pancreatic Duct Secondary to Remote Trauma: A Long-term Complication of Seat Belt Pancreatitis.
- Author
-
Wu AA, Thompson ED, Cameron JL, He J, Burkhart RA, Burns WR, Lafaro KJ, Shubert CR, Canto MI, Fishman EK, and Hruban RH
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Abdominal Injuries pathology, Abdominal Injuries complications, Abdominal Injuries etiology, Constriction, Pathologic etiology, Fibrosis, Wounds, Nonpenetrating complications, Wounds, Nonpenetrating pathology, Wounds, Nonpenetrating etiology, Accidents, Traffic, Pancreatic Ducts pathology, Pancreatic Ducts injuries, Pancreatitis etiology, Pancreatitis pathology, Seat Belts adverse effects
- Abstract
The radiologic finding of focal stenosis of the main pancreatic duct is highly suggestive of pancreatic cancer. Even in the absence of a mass lesion, focal duct stenosis can lead to surgical resection of the affected portion of the pancreas. We present four patients with distinctive pathology associated with non-neoplastic focal stenosis of the main pancreatic duct. The pathology included stenosis of the pancreatic duct accompanied by wavy, acellular, serpentine-like fibrosis, chronic inflammation with foreign body-type giant cell reaction, and calcifications. In all cases, the pancreas toward the tail of the gland had obstructive changes including acinar drop-out and interlobular and intralobular fibrosis. Three of the four patients had a remote history of major motor vehicle accidents associated with severe abdominal trauma. These results emphasize that blunt trauma can injure the pancreas and that this injury can result in long-term complications, including focal stenosis of the main pancreatic duct. Pathologists should be aware of the distinct pathology associated with remote trauma and, when the pathology is present, should elicit the appropriate clinical history., Competing Interests: Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
21. Difficulty encountered in the early radiological diagnosis of atypical pancreatic duct stones compared to the typical type in Chinese patients.
- Author
-
Hou C, Li R, Chen Q, Jin L, Hu B, Meng X, and Zhang J
- Subjects
- Humans, Female, Male, Middle Aged, Asian People, China, Adult, Calculi diagnostic imaging, Aged, Pancreatic Diseases diagnostic imaging, Early Diagnosis, Tomography, X-Ray Computed, Cholangiopancreatography, Magnetic Resonance, Cholangiopancreatography, Endoscopic Retrograde, East Asian People, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology
- Published
- 2024
- Full Text
- View/download PDF
22. Inversin-deficient (inv) mice do not establish a polarized duct system in the liver and pancreas.
- Author
-
Fujisawa H, Ota N, and Shiojiri N
- Subjects
- Animals, Mice, Animals, Newborn, Cell Polarity physiology, Epithelial Cells metabolism, Epithelial Cells pathology, Hepatocyte Nuclear Factor 1-beta metabolism, Hepatocyte Nuclear Factor 1-beta genetics, SOX9 Transcription Factor metabolism, Bile Ducts, Intrahepatic metabolism, Bile Ducts, Intrahepatic pathology, Liver metabolism, Liver pathology, Pancreas metabolism, Pancreas pathology, Pancreatic Ducts metabolism, Pancreatic Ducts pathology
- Abstract
Inversin-deficient (inv) mice have anomalies in liver and pancreatic development in addition to an inverted left-right axis of the body. The present study was undertaken to unveil mechanisms of bile and pancreatic duct development from immunohistochemical analyses of anomalies in inv mice. Intrahepatic bile ducts having proximodistal polarity in size and the height of their epithelia, and ductules were formed in livers of wild-type neonates. By contrast, in inv mice, ductal plates, precursor structures of intrahepatic bile ducts and ductules, persisted without the proximodistal polarity. Their epithelial cells did not acquire planar cell polarity (PCP) in terms of expression of tight junction proteins although they expressed bile duct markers, HNF1β and SOX9. They had an apicobasal polarity from expression of basal laminar components. Enlargement of the hepatic artery and poor connective tissue development, including the abnormal deposition of the extracellular matrices, were also noted in inv mice, suggesting that bile duct development was coupled to that of the hepatic artery and portal vein. In pancreata of inv neonates, neither the main pancreatic duct was formed, nor dilated duct-like structures had the morphological polarity from the connecting point with the common bile duct. Lumina of acini was dilated, and centroacinar cells changed their position in the acini to their neck region. Immunohistochemical analyses of tight junction proteins suggested that epithelial cells of the duct-like structures did not have a PCP. Thus, Invs may be required for the establishment of the PCP of the whole duct system in the liver and pancreas., (© 2023 American Association for Anatomy.)
- Published
- 2024
- Full Text
- View/download PDF
23. Abdominal ultrasound in the characterization of branch-duct intraductal papillary mucinous neoplasms: A new tool for surveillance of low-risk patients?
- Author
-
Ferronato M, Lizzio CE, Berardinelli D, Marini D, Elia E, Andreetto L, Trentini A, Potenza MC, Serra C, Mazzotta E, Ricci C, Casadei R, and Migliori M
- Subjects
- Humans, Female, Male, Aged, Prospective Studies, Middle Aged, Reproducibility of Results, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms pathology, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Carcinoma, Pancreatic Ductal diagnostic imaging, Carcinoma, Pancreatic Ductal pathology, Aged, 80 and over, Adenocarcinoma, Mucinous diagnostic imaging, Adenocarcinoma, Mucinous pathology, Magnetic Resonance Imaging, Ultrasonography methods, Pancreatic Intraductal Neoplasms diagnostic imaging, Pancreatic Intraductal Neoplasms pathology
- Abstract
Background: Magnetic resonance imaging (MRI) is regarded as gold-standard for intraductal papillary mucinous neoplasms (IPMNs) follow-up. Given the low risk of transformation and the increasing population under surveillance, there is growing interest in identifying optimal follow-up strategies., Aim: To evaluate reliability of abdominal ultrasound (US) for characterization of low-risk IPMN, compared to MRI., Methods: Prospective monocentric study among 79 consecutive patients with a suspected BD-IPMN on US. Each patient underwent confirmatory MRI. We evaluated Cohen's kappa statistic and concordance rate (CR) between MRI and US., Results: Of 79 suspected IPMNs on US, MRI confirmed 71 BD-IPMNs. There was high agreement for cyst location and number (CR and kappa of 77.5 % and 81.7 % and 0.66±0.08 and 0.62±0.11 respectively). We found high agreement for cyst size (CR=96.5 %, kappa=0.93±0.05) and main pancreatic duct (MPD) dilatation (CR=100 %, kappa=1). There was a good agreement for thickened septa (CR=80.3 %, kappa=0.38±0.12). US seems inferior to MRI for the identification of mural nodules < 5 mm (CR=97.2 %, kappa=0)., Conclusions: In a cohort of low-risk BD-IPMN, US presented high agreement rate with MRI regarding location, number, and size. There was a good agreement for MPD dilatation and thickened septa, while US underperform for detection of mural nodules < 5 mm., Competing Interests: Conflict of interest Nothing to report., (Copyright © 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
24. [Intraductal mixed acinar ductal carcinoma of pancreas: report of a case].
- Author
-
Yu J, Xiao GX, Liu C, Xie LL, Yang XP, and Zheng LD
- Subjects
- Humans, Female, Middle Aged, beta Catenin metabolism, Pancreatic Ducts pathology, Keratins metabolism, Pancreatitis, Chronic pathology, Pancreatitis, Chronic metabolism, Pancreatitis, Chronic diagnosis, Carcinoma, Acinar Cell pathology, Carcinoma, Acinar Cell diagnosis, Carcinoma, Acinar Cell metabolism, Pancreatic Neoplasms pathology, Pancreatic Neoplasms metabolism, Pancreatic Neoplasms diagnosis, Carcinoma, Pancreatic Ductal metabolism, Carcinoma, Pancreatic Ductal pathology, Carcinoma, Pancreatic Ductal diagnosis
- Published
- 2024
- Full Text
- View/download PDF
25. Oncogenic GNAS Uses PKA-Dependent and Independent Mechanisms to Induce Cell Proliferation in Human Pancreatic Ductal and Acinar Organoids.
- Author
-
Desai R, Huang L, Gonzalez RS, and Muthuswamy SK
- Subjects
- Humans, Carcinoma, Pancreatic Ductal pathology, Carcinoma, Pancreatic Ductal genetics, Carcinoma, Pancreatic Ductal metabolism, Pancreatic Ducts metabolism, Pancreatic Ducts pathology, Pancreatic Ducts cytology, Acinar Cells metabolism, Acinar Cells pathology, GTP-Binding Protein alpha Subunits, Gs metabolism, GTP-Binding Protein alpha Subunits, Gs genetics, Cell Proliferation, Organoids metabolism, Organoids pathology, Chromogranins genetics, Chromogranins metabolism, Cyclic AMP-Dependent Protein Kinases metabolism, Cyclic AMP-Dependent Protein Kinases genetics, Pancreatic Neoplasms pathology, Pancreatic Neoplasms genetics, Pancreatic Neoplasms metabolism
- Abstract
Implications: The study identifies an opportunity to discover a PKA-independent pathway downstream of oncogene GNAS for managing IPMN lesions and their progression to PDAC., (©2024 American Association for Cancer Research.)
- Published
- 2024
- Full Text
- View/download PDF
26. Value of the surgical pancreatic duct anatomy and associated outcomes in pancreatic cancer.
- Author
-
Harris MC, Atanasov G, Neo EN, Goldfinch A, Ng AJ, Tew K, Kuan L, Trochsler M, and Kanhere H
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Retrospective Studies, Neoplasm Recurrence, Local epidemiology, Treatment Outcome, Prognosis, Pancreatic Neoplasms surgery, Pancreatic Neoplasms pathology, Pancreatic Neoplasms mortality, Pancreatic Ducts pathology, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts surgery, Pancreaticoduodenectomy methods
- Abstract
Introduction: Pancreatic cancer recurrence following surgery is a significant challenge, and personalized surgical care is crucial. Topographical variations in pancreatic duct anatomy are frequent but often underestimated. This study aimed to investigate the potential importance of these variations in outcomes and patient survival after Whipple's procedures., Methods: Data were collected from 105 patients with confirmed pancreatic head neoplasms who underwent surgery between 2008 and 2020. Radiological measurements of pancreatic duct location were performed, and statistical analysis was carried out using IBM SPSS., Results: Inferior pancreatic duct topography was associated with an increased rate of metastatic spread and tumour recurrence. Additionally, inferior duct topography was associated with reduced overall and recurrence-free survival. Posterior pancreatic duct topography was associated with decreased incidence of perineural sheet infiltration and improved overall survival., Discussion: These findings suggest that topographical diversity of pancreatic duct location can impact outcomes in Whipple's procedures. Intraoperative review of pancreatic duct location could help surgeons define areas of risk or safety and deliver a personalized surgical approach for patients with beneficial or deleterious anatomical profiles. This study provides valuable information to improve surgical management by identifying high-risk patients and delivering a personalized surgical approach with prognosis stratification., (© 2024 Royal Australasian College of Surgeons.)
- Published
- 2024
- Full Text
- View/download PDF
27. Single-cell transcriptomics reveals a role for pancreatic duct cells as potential mediators of inflammation in diabetes mellitus.
- Author
-
Muñoz García A, Juksar J, Groen N, Zaldumbide A, de Koning E, and Carlotti F
- Subjects
- Humans, Gene Expression Profiling, Diabetes Mellitus immunology, Diabetes Mellitus genetics, Diabetes Mellitus metabolism, Cells, Cultured, Inflammation Mediators metabolism, Pancreatic Ducts pathology, Pancreatic Ducts metabolism, Pancreatic Ducts immunology, Single-Cell Analysis, Transcriptome, Inflammation immunology, Inflammation genetics
- Abstract
Introduction: Inflammation of the pancreas contributes to the development of diabetes mellitus. Although it is well-accepted that local inflammation leads to a progressive loss of functional beta cell mass that eventually causes the onset of the disease, the development of islet inflammation remains unclear., Methods: Here, we used single-cell RNA sequencing to explore the cell type-specific molecular response of primary human pancreatic cells exposed to an inflammatory environment., Results: We identified a duct subpopulation presenting a unique proinflammatory signature among all pancreatic cell types., Discussion: Overall, the findings of this study point towards a role for duct cells in the propagation of islet inflammation, and in immune cell recruitment and activation, which are key steps in the pathophysiology of diabetes mellitus., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Muñoz García, Juksar, Groen, Zaldumbide, de Koning and Carlotti.)
- Published
- 2024
- Full Text
- View/download PDF
28. Persistent chronic calcific pancreatitis with intraductal calculi associated with secondary diabetes mellitus type 3 and diabetic ketoacidosis - A case report.
- Author
-
Bahl G, Upadhyay DK, Varma M, Singh R, Das S, and Hussain S
- Subjects
- Humans, Male, Adult, Tomography, X-Ray Computed, Diabetic Ketoacidosis complications, Diabetic Ketoacidosis diagnosis, Pancreatitis, Chronic complications, Pancreatitis, Chronic diagnosis, Pancreatitis, Chronic diagnostic imaging, Calculi complications, Calculi diagnostic imaging, Calculi diagnosis, Pancreatic Ducts pathology, Pancreatic Ducts diagnostic imaging, Calcinosis etiology, Calcinosis diagnosis, Calcinosis complications, Calcinosis diagnostic imaging
- Abstract
Diabetes mellitus type 3 refers to diabetes secondary to an existing disease or condition of the exocrine pancreas and is an uncommon cause of diabetes occurring due to pancreatogenic pathology. It accounts for 15-20% of diabetic patients in Indian and Southeast Asian continents. This is case report of a rare case of type 3 diabetes mellitus (T3DM) presenting with diabetic ketoacidosis (DKA). The patient was admitted for DKA along with complaint of hyperglycemia, blood glucose of 405 mg/dl with HbA1c level of 13.7%. Computed tomography evidence revealed chronic calcific pancreatitis with intraductal calculi and dilated pancreatic duct., (© 2024 Gurusha Bahl et al., published by Sciendo.)
- Published
- 2024
- Full Text
- View/download PDF
29. Endoscopic papillectomy for ampullary lesions of minor papilla.
- Author
-
Vu Trung K, Heise C, Abou-Ali E, Auriemma F, Karam E, van der Wiel SE, Bruno MJ, Caillol F, Giovannini M, Masaryk V, Will U, Anderloni A, Pérez-Cuadrado-Robles E, Dugic A, Meier B, Paik WH, Petrone MC, Wichmann D, Dinis-Ribeiro M, Gonçalves TC, Wedi E, Schmidt A, Gulla A, Hoffmeister A, Rosendahl J, Ratone JP, Saadeh R, Repici A, Deprez P, Sauvanet A, Souche FR, Fabre JM, Muehldorfer S, Caca K, Löhr M, Michl P, Krug S, Regner S, Gaujoux S, and Hollenbach M
- Subjects
- Humans, Treatment Outcome, Endoscopy, Gastrointestinal, Pancreatic Ducts pathology, Retrospective Studies, Ampulla of Vater surgery, Ampulla of Vater pathology, Pancreatic Neoplasms pathology, Duodenal Neoplasms pathology, Common Bile Duct Neoplasms surgery, Common Bile Duct Neoplasms pathology
- Abstract
Background and Aims: Ampullary lesions (ALs) of the minor duodenal papilla are extremely rare. Endoscopic papillectomy (EP) is a routinely used treatment for AL of the major duodenal papilla, but the role of EP for minor AL has not been accurately studied., Methods: We identified 20 patients with ALs of minor duodenal papilla in the multicentric database from the Endoscopic Papillectomy vs Surgical Ampullectomy vs Pancreatitcoduodenectomy for Ampullary Neoplasm study, which included 1422 EPs. We used propensity score matching (nearest-neighbor method) to match these cases with ALs of the major duodenal papilla based on age, sex, histologic subtype, and size of the lesion in a 1:2 ratio. Cohorts were compared by means of chi-square or Fisher exact test as well as Mann-Whitney U test., Results: Propensity score-based matching identified a cohort of 60 (minor papilla 20, major papilla 40) patients with similar baseline characteristics. The most common histologic subtype of lesions of minor papilla was an ampullary adenoma in 12 patients (3 low-grade dysplasia and 9 high-grade dysplasia). Five patients revealed nonneoplastic lesions. Invasive cancer (T1a), adenomyoma, and neuroendocrine neoplasia were each found in 1 case. The rate of complete resection, en-bloc resection, and recurrences were similar between the groups. There were no severe adverse events after EP of lesions of minor papilla. One patient had delayed bleeding that could be treated by endoscopic hemostasis, and 2 patients showed a recurrence in surveillance endoscopy after a median follow-up of 21 months (interquartile range, 12-50 months)., Conclusions: EP is safe and effective in ALs of the minor duodenal papilla. Such lesions could be managed according to guidelines for EP of major duodenal papilla., Competing Interests: Disclosure The following authors disclosed financial relationships: M. Bruno: honoraria from Boston Scientific for lectures and research support. E. Wedi and A. Schmidt: honoraria from Ovesco for lectures and research support. M. Hollenbach: honoraria from Fujifilm for lectures and expert panel. All of the other authors disclosed no financial relationships., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
30. Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis.
- Author
-
Sagami R, Yamao K, Minami R, Nakahodo J, Akiyama H, Nishikiori H, Mizukami K, Yamao K, Bhatia V, Amano Y, and Murakami K
- Subjects
- Humans, Constriction, Pathologic diagnostic imaging, Constriction, Pathologic pathology, Endosonography, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Retrospective Studies, Carcinoma in Situ diagnostic imaging, Carcinoma in Situ pathology, Carcinoma, Pancreatic Ductal pathology, Pancreatic Neoplasms pathology
- Abstract
Background/aims: High-grade pancreatic intraepithelial neoplasia and invasive pancreatic ductal adenocarcinoma ≤10 mm are targets for early detection of pancreatic cancer. However, their imaging characteristics are unknown. We aimed to identify endoscopic ultrasound findings for the detection of these lesions., Methods: Patients diagnosed with high-grade pancreatic intraepithelial neoplasia (n=29), pancreatic ductal adenocarcinoma ≤10 mm (n=11) (who underwent surgical resection), or benign main pancreatic duct stenosis (n=20) between January 2014 and January 2021 were retrospectively included. Six features differentiating these lesions were examined by endoscopic ultrasonography: main pancreatic duct stenosis, upstream main pancreatic duct dilation, hypoechoic areas surrounding the main pancreatic duct irregularities (mottled areas without demarcation or round areas with demarcation), branch duct dilation, prominent lobular segmentation, and atrophy. Interobserver agreement was assessed by two independent observers., Results: Hypoechoic areas surrounding the main pancreatic duct irregularities were observed more frequently in high-grade pancreatic intraepithelial neoplasia (82.8%) and pancreatic ductal adenocarcinoma ≤10 mm (90.9%) than in benign stenosis (15.0%) (p<0.001). High-grade pancreatic intraepithelial neoplasia exhibited mottled hypoechoic areas more frequently (79.3% vs 18.9%, p<0.001), and round hypoechoic areas less frequently (3.4% vs 72.7%, p<0.001), than pancreatic ductal adenocarcinoma ≤10 mm. The sensitivity and specificity of hypoechoic areas for differentiating high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma ≤10 mm, and benign stenosis were both 85.0%, with moderate interobserver agreement., Conclusions: The hypoechoic areas surrounding main pancreatic duct irregularities on endoscopic ultrasound may differentiate between high-grade pancreatic intraepithelial neoplasia, pancreatic ductal adenocarcinoma ≤10 mm, and benign stenosis (Trial Registration: UMIN Clinical Trials Registry (UMIN000044789).
- Published
- 2024
- Full Text
- View/download PDF
31. Current considerations on intraductal papillary neoplasms of the bile duct and pancreatic duct.
- Author
-
Pavlidis ET, Galanis IN, and Pavlidis TE
- Subjects
- Humans, Bile Ducts, Intrahepatic diagnostic imaging, Bile Ducts, Intrahepatic pathology, Bile Ducts pathology, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Bile Duct Neoplasms surgery, Bile Duct Neoplasms genetics, Cholangiocarcinoma surgery, Cholangiocarcinoma genetics, Pancreatic Neoplasms surgery, Pancreatic Neoplasms pathology
- Abstract
Pancreatobiliary intraductal papillary neoplasms (IPNs) represent precursors of pancreatic cancer or bile duct cholangiocarcinoma that can be detected and treated. Despite advances in diagnostic methods, identifying these premalignant lesions is still challenging for treatment providers. Modern imaging, biomarkers and molecular tests for genomic alterations can be used for diagnosis and follow-up. Surgical intervention in combination with new chemotherapeutic agents is considered the optimal treatment for malignant cases. The balance between the risk of malignancy and any risk of resection guides management policy; therefore, treatment should be individualized based on a meticulous preoperative assessment of high-risk stigmata. IPN of the bile duct is more aggressive; thus, early diagnosis and surgery are crucial. The conservative management of low-risk pancreatic branch-duct lesions is safe and effective., Competing Interests: Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article., (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. Cell of Origin of Pancreatic cancer: Novel Findings and Current Understanding.
- Author
-
Zheng C, Wang J, Wang J, Zhang Q, and Liang T
- Subjects
- Mice, Animals, Pancreas pathology, Acinar Cells metabolism, Pancreatic Ducts pathology, Pancreatic Neoplasms pathology, Carcinoma, Pancreatic Ductal pathology
- Abstract
Abstract: Pancreatic ductal adenocarcinoma (PDAC) stands as one of the most lethal diseases globally, boasting a grim 5-year survival prognosis. The origin cell and the molecular signaling pathways that drive PDAC progression are not entirely understood. This review comprehensively outlines the categorization of PDAC and its precursor lesions, expounds on the creation and utility of genetically engineered mouse models used in PDAC research, compiles a roster of commonly used markers for pancreatic progenitors, duct cells, and acinar cells, and briefly addresses the mechanisms involved in the progression of PDAC. We acknowledge the value of precise markers and suitable tracing tools to discern the cell of origin, as it can facilitate the creation of more effective models for PDAC exploration. These conclusions shed light on our existing understanding of foundational genetically engineered mouse models and focus on the origin and development of PDAC., Competing Interests: The authors declare no conflict of interest., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
33. Robotic Enucleation of Pancreatic Head Insulinomas in Close Proximity to the Pancreatic Duct.
- Author
-
Polanco PM, Karalis JD, Abreu AA, Weis J, and Zeh HJ 3rd
- Subjects
- Male, Female, Humans, Aged, Middle Aged, Pancreatectomy methods, Pancreatic Ducts pathology, Hypoglycemic Agents, Insulinoma surgery, Robotic Surgical Procedures methods, Pancreatic Neoplasms surgery, Laparoscopy methods, Head and Neck Neoplasms surgery
- Abstract
Background: Insulinomas are rare pancreatic neuroendocrine tumors for which the main curative treatment is surgical resection. Enucleation is preferred over pancreatoduodenectomy to minimize morbidity and function loss.
1 Robotic-assisted surgery offers improved versatility and less blood loss than laparoscopic surgery for pancreatic enucleation.2-4 Our video describes the technique for robotic enucleation of pancreatic head insulinomas in close proximity to the pancreatic duct., Patients and Methods: The video describes the presentation, diagnostic imaging, and technical aspects of the surgical approach in two patients with pancreatic head insulinomas that underwent robotic enucleation., Results: Case one was a 76-year-old woman who experienced syncope for 2 months. Case two was a 61-year-old man, previously treated for renal cancer, who had documented hypoglycemic symptoms. Computed tomography (CT) scan and magnetic resonance imaging (MRI) identified a 1.5 cm and 1.2 cm pancreatic head mass, respectively. Both patients presented with low glucose levels, and elevated C-peptide and proinsulin. In both cases, endoscopic retrograde cholangiopancreatography (ERCP) and pancreatic duct stent placement were performed the same day of surgery for intraoperative identification and preservation of the duct. Robotic enucleation of the masses was performed, and an ultrasound was used to identify the masses and relation with main pancreatic duct. Pathology revealed a well-differentiated neuroendocrine tumor in both cases. The patient's postoperative course was uneventful, and they were discharged on day 5. Successful resolution of hypoglycemic events occurred in both patients., Conclusion: Robotic enucleation is a safe and feasible option for treating pancreatic head tumors in challenging locations. Intraoperative ultrasound is an essential tool for the successful robotic enucleation of pancreatic head tumors., (© 2023. Society of Surgical Oncology.)- Published
- 2024
- Full Text
- View/download PDF
34. Correlation between main pancreatic duct diameter measurements: Special pancreatic ultrasonography versus magnetic resonance cholangiopancreatography.
- Author
-
Ikezawa K, Fukuda J, Nakao M, Nakano Y, Higashi C, Chagi M, Nakaya Y, and Ohkawa K
- Subjects
- Humans, Retrospective Studies, Pancreas diagnostic imaging, Pancreas pathology, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Magnetic Resonance Imaging methods, Ultrasonography, Cholangiopancreatography, Magnetic Resonance methods, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms pathology
- Abstract
Main pancreatic duct (MPD) dilatation is reported to be a risk factor for pancreatic cancer (PC). Although magnetic resonance cholangiopancreatography (MRCP) and ultrasonographic modalities are valuable for monitoring the pancreas, there is limited information on the efficacy of different imaging modalities in measuring MPD diameter. To improve pancreatic imaging, we developed a specialized ultrasound approach focusing on the pancreas (special pancreatic US). We aimed to examine the correlation between MPD diameter measurements using special pancreatic US versus MRCP. We retrospectively reviewed the clinical data of patients with MPD dilation (≥2.5 mm) via special pancreatic US used for screening at our institution between January 2020 and October 2022 and included patients who underwent magnetic resonance imaging 2 months before and after pancreatic US. The MPD diameter on MRCP was measured at the pancreatic locus, where the maximum MPD diameter was obtained on special pancreatic US. This study included 96 patients, with a median interval of 8.5 days between the date of special pancreatic US and the date of undergoing MRCP. MPD dilatation and/or pancreatic cysts were diagnosed in 86 patients, PC in 5 patients, and other diseases in 5 patients. The median MPD diameter, measured using special pancreatic US, was 3.4 mm (interquartile range: 2.9-4.9 mm), whereas it was 3.5 mm using MRCP (interquartile range: 2.8-4.5 mm). There were strong positive correlations between MPD diameter measured on special pancreatic US and that measured on MRCP (R = 0.925, P < .001). This study revealed strong positive correlations between the MPD diameter measurements using special pancreatic US and MRCP. MPD diameter measurements from each imaging method can be helpful during follow-up in individuals at a high risk of PC., Competing Interests: The authors have no funding and conflicts of interest to disclose., (Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
35. A case report of carcinoma of the papilla of Vater associated with a hyperplasia-dysplasia-carcinoma sequence by pancreaticobiliary maljunction.
- Author
-
Korai T, Kimura Y, Watanabe K, Low SK, Imamura M, Nagayama M, Kukita K, Murakami T, Kato T, Kondo Y, Kyuno D, Sugawara T, Murota A, Kawakami Y, Masaki Y, Nakase H, and Takemasa I
- Subjects
- Humans, Female, Aged, Hyperplasia surgery, Hyperplasia pathology, Pancreatic Ducts pathology, Bile Ducts surgery, Bile Ducts pathology, Pancreaticobiliary Maljunction, Biliary Tract pathology, Biliary Tract Neoplasms, Carcinoma pathology, Gallbladder Neoplasms surgery, Gallbladder Neoplasms pathology
- Abstract
Background: Pancreaticobiliary maljunction (PBM) is a known risk factor for biliary tract cancer. However, its association with carcinoma of the papilla of Vater (PVca) remains unknown. We report a case with PVca that was thought to be caused by the hyperplasia-dysplasia-carcinoma sequence, which is considered a mechanism underlying PBM-induced biliary tract cancer., Case Presentation: A 70-year-old woman presented with white stool and had a history of cholecystectomy for the diagnosis of a non-dilated biliary tract with PBM. Esophagogastroduodenoscopy revealed a tumor in the papilla of Vater, and PVca was histologically proven by biopsy. We finally diagnosed her with PVca concurrent with non-biliary dilated PBM (cT1aN0M0, cStage IA, according to the Union for International Cancer Control, 8th edition), and subsequently performed subtotal stomach-preserving pancreaticoduodenectomy. Pathological findings of the resected specimen revealed no adenomas and dysplastic and hyperplastic mucosae in the common channel slightly upstream of the main tumor, suggesting a PBM related carcinogenic pathway with hyperplasia-dysplasia-carcinoma sequence. Immunostaining revealed positivity for CEA. CK7 positivity, CK20 negativity, and MUC2 negativity indicated that this PVca was of the pancreatobiliary type. Genetic mutations were exclusively detected in tumors and not in normal tissues, and bile ducts from formalin-fixed paraffin-embedded samples included mutated-ERBB2 (Mutant allele frequency, 81.95%). Moreover, of the cell-free deoxyribonucleic acid (cfDNA) extracted from liquid biopsy mutated-ERBB2 was considered the circulating-tumor deoxyribonucleic acid (ctDNA) of this tumor., Conclusions: Herein, we report the first case of PVca with PBM potentially caused by a "hyperplasia-dysplasia-carcinoma sequence" detected using immunostaining and next-generation sequencing. Careful follow-up is required if pancreaticobiliary reflux persists, considering the possible development of PVca., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
36. Emerging Therapeutic Options in Pancreatic Cancer Management.
- Author
-
Delle Cave D
- Subjects
- Humans, Pancreatic Ducts pathology, Survival Rate, Pancreatic Neoplasms drug therapy, Carcinoma, Pancreatic Ductal drug therapy
- Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a 5-year survival rate of <8% [...].
- Published
- 2024
- Full Text
- View/download PDF
37. A case of congenital biliary dilatation without pancreaticobiliary maljunction, so-called Type Ib according to Todani's classification.
- Author
-
Kiyoshita Y, Ishii Y, Serikawa M, Nakamura S, Ikemoto J, Tamura Y, Miyamoto S, Nakamura K, Furukawa M, and Oka S
- Subjects
- Male, Humans, Adult, Cholangiopancreatography, Endoscopic Retrograde methods, Dilatation, Pathologic diagnostic imaging, Dilatation, Pathologic congenital, Dilatation, Pathologic pathology, Pancreatic Ducts pathology, Choledochal Cyst pathology, Choledochal Cyst surgery, Pancreaticobiliary Maljunction, Bile Ducts, Extrahepatic, Biliary Tract Neoplasms
- Abstract
Congenital biliary dilatation (CBD) is a congenital malformation of focal dilatation of the extrahepatic bile ducts, including the common bile duct, and is often associated with pancreaticobiliary maljunction (PBM). In this article, we report a CBD case that presented with focal dilation of the common bile duct without PBM (Todani's classification type Ib). The patient was a 32-year-old man who visited a doctor with a chief complaint of abdominal distension. Computed tomography revealed cystic dilatation of the common bile duct, and the patient was referred to our institution. Magnetic resonance cholangiopancreatography showed cystic dilatation of the common bile duct with a maximum diameter of 7 cm; however, evaluating the presence of PBM was challenging. Endoscopic ultrasonography showed small gallstones and debris in the dilated common bile duct and no thickening of the gallbladder wall. Endoscopic retrograde cholangiopancreatography revealed no PBM or markedly elevated bile amylase levels. Based on these findings, the patient was diagnosed with Todani Type Ib CBD. Since this patient did not have pancreatobiliary reflux, it was unclear whether the risk of developing biliary tract cancer was high, and since the treatment was highly invasive, the decision was to follow up without surgical treatment., (© 2023. Japanese Society of Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
38. Choledochocele with hyperplastic epithelium in a patient who developed severe acute pancreatitis and underwent subtotal stomach-preserving pancreatoduodenectomy: a case report.
- Author
-
Hayasaki A, Tanemura A, Uchida K, Nagata M, Yamada R, Fujii T, Murata Y, Kuriyama N, Kishiwada M, and Mizuno S
- Subjects
- Humans, Pancreaticoduodenectomy adverse effects, Pancreatic Ducts pathology, Hyperplasia pathology, Acute Disease, Stomach pathology, Epithelium pathology, Choledochal Cyst complications, Choledochal Cyst diagnostic imaging, Choledochal Cyst surgery, Pancreatitis etiology, Pancreatitis surgery, Pancreaticobiliary Maljunction complications
- Abstract
Choledochocele is defined as a congenital dilatation of the distal intramural part of the common bile duct protruding into the wall of the descending duodenum, typically without pancreaticobiliary maljunction. However, some cases present with a similar pathophysiology to pancreaticobiliary maljunction, including reciprocal reflux of pancreatic juices and bile, leading to protein plugs, pancreatitis, and biliary tract carcinogenesis. Choledochocele is relatively rare and its anatomy, physiology, pathology, and clinical features are thus not well known. We describe a patient with choledochocele who suffered from repeated severe acute pancreatitis and underwent subtotal stomach-preserving pancreatoduodenectomy, in whom the pathological findings of choledochocele showed hyperplasia., (© 2023. Japanese Society of Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
39. A case of acute recurrent pancreatitis caused by biliopancreatic reflux without pancreaticobiliary maljunction.
- Author
-
Horitani S, Sanuki T, Fujigaki S, Tabuchi J, Tabuchi K, Shirohata A, Ariyoshi R, Tanaka K, Morikawa T, and Kinoshita Y
- Subjects
- Male, Humans, Middle Aged, Acute Disease, Cholangiopancreatography, Endoscopic Retrograde methods, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Pancreatitis diagnostic imaging, Pancreatitis etiology, Pancreaticobiliary Maljunction complications
- Abstract
Acute recurrent pancreatitis (ARP) is a clinical condition characterized by repeated episodes of acute pancreatitis. In this case study, a 62-year-old man was diagnosed with mild pancreatitis five years ago, with alcohol intake initially considered the cause. Since then, he experienced three episodes of pancreatitis despite ceasing alcohol consumption completely. Consequently, the patient was diagnosed with ARP. Various diagnostic and imaging tests were performed to determine the etiology of his condition, including blood tests, magnetic resonance cholangiopancreatography, endoscopic ultrasonography, and contrast-enhanced computed tomography. The results were inconclusive; however, endoscopic retrograde cholangiopancreatography revealed the reflux of bile and pancreatic juice into the alternative ducts, despite the absence of anatomical abnormalities in the biliary tract or pancreatic duct. These findings subsequently led to the diagnosis of biliopancreatic reflux, which activated pancreatic enzymes causing ARP. Endoscopic biliary sphincterotomy was performed to alleviate the patient's symptoms. One year later, the patient remained symptom-free. This case highlights the importance of examining bile and pancreatic juice components before considering endoscopic sphincterotomy in patients with unexplained ARP., (© 2023. Japanese Society of Gastroenterology.)
- Published
- 2024
- Full Text
- View/download PDF
40. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review.
- Author
-
Ohno E, Balduzzi A, Hijioka S, De Pastena M, Marchegiani G, Kato H, Takenaka M, Haba S, and Salvia R
- Subjects
- Humans, Acute Disease, Carcinoma, Pancreatic Ductal diagnosis, Carcinoma, Pancreatic Ductal pathology, Cysts pathology, Pancreatic Ducts pathology, Pancreatitis pathology, Retrospective Studies, Neoplasms, Cystic, Mucinous, and Serous diagnosis, Neoplasms, Cystic, Mucinous, and Serous pathology, Pancreatic Intraductal Neoplasms diagnosis, Pancreatic Intraductal Neoplasms pathology, Pancreatic Neoplasms pathology
- Abstract
Background: This systematic review aimed to assess the diagnostic accuracy of the International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of Intraductal Papillary Mucinous Neoplasms (IPMNs)., Methods: The ICG2017 revision committee conducted a comprehensive literature review to establish evidence-based statements on IPMNs. The review focused on articles examining the diagnostic value of imaging features (e.g., cyst or main pancreatic duct diameter), clinical symptoms associated with IPMN, and serum biomarkers. Five clinical questions regarding high-risk stigmata (HRS) and worrisome features (WF) in the ICG2017 guidelines were addressed., Results: A total of 210 articles were reviewed. The findings revealed a significant association between the presence of mural nodules ≥5 mm in diameter or solid components with contrast enhancement and the diagnosis of high-grade dysplasia or invasive carcinoma. Contrast-enhanced diagnostic tools, such as CT, MRI, or EUS, demonstrated the highest prediction rate and were recommended. Positive cytology was identified as an HRS, while symptoms like acute pancreatitis and cyst diameter growth ≥2.5 mm per year were considered WFs. The use of nomograms and multiple diagnostic factors was recommended for optimal IPMN management., Conclusions: This systematic review provides evidence supporting the improved diagnostic accuracy of ICG2017 in identifying high-risk lesions of IPMN. The multidisciplinary incorporation of HRS and WF based on imaging findings and clinical symptoms is crucial. These findings should inform the revision of ICG2017, enhancing the evaluation and management of IPMN patients. By implementing these recommendations, clinicians can make more informed decisions, leading to better diagnosis and treatment outcomes for high-risk IPMN cases., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
41. Imaging Diagnosis and Management of Fistulas in Pancreatitis.
- Author
-
Chhabra M, Gupta P, Shah J, Samanta J, Mandavdhare H, Sharma V, Sinha SK, Dutta U, and Kochhar R
- Subjects
- Humans, Pancreatic Fistula diagnostic imaging, Pancreatic Fistula etiology, Pancreatic Fistula therapy, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreas diagnostic imaging, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Magnetic Resonance Imaging, Pancreatitis complications, Pancreatitis diagnostic imaging, Pancreatic Diseases pathology
- Abstract
Pancreatic fistula is a highly morbid complication of pancreatitis. External pancreatic fistulas result when pancreatic secretions leak externally into the percutaneous drains or external wound (following surgery) due to the communication of the peripancreatic collection with the main pancreatic duct (MPD). Internal pancreatic fistulas include communication of the pancreatic duct (directly or via intervening collection) with the pleura, pericardium, mediastinum, peritoneal cavity, or gastrointestinal tract. Cross-sectional imaging plays an essential role in the management of pancreatic fistulas. With the help of multiplanar imaging, fistulous tracts can be delineated clearly. Thin computed tomography sections and magnetic resonance cholangiopancreatography images may demonstrate the communication between MPD and pancreatic fluid collections or body cavities. Endoscopic retrograde cholangiography (ERCP) is diagnostic as well as therapeutic. In this review, we discuss the imaging diagnosis and management of various types of pancreatic fistulas with the aim to sensitize radiologists to timely diagnosis of this critical complication of pancreatitis., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
42. Fine-needle aspiration of a pancreas with squamoid cyst of pancreatic duct and pancreatic duct stones: A case report of a rare pancreatic lesion and an unusual concurrent finding of stone-related crystals.
- Author
-
Pang YH and Ooi LY
- Subjects
- Humans, Biopsy, Fine-Needle, Pancreas pathology, Pancreatic Ducts pathology, Pancreatic Cyst pathology, Pancreatic Neoplasms pathology
- Abstract
Squamoid cyst of pancreatic duct is a rare benign pancreatic lesion that is rarely encountered in fine-needle aspiration (FNA) and surgical resection specimens. Pancreatic stones can be seen in chronic pancreatitis, but stone-related crystals have previously not been described in pancreatic cytology. Presented here is a case report of a squamoid cyst of pancreatic duct with concurrent pancreatic duct stones. We describe the cytomorphology of this benign cyst, as well as the remarkable finding of polymorphous crystals on cyst fluid aspirate. We also describe the histology of the surgically resected cystic lesion. With the increase in detection of incidental pancreatic cysts on imaging, this case highlights the importance of awareness and recognition of benign non-neoplastic epithelial cysts on FNA sampling to avoid overtreatment. The presence of crystals on pancreatic FNA is an unusual finding, likely representing calcium carbonate crystals related to the formation of pancreatic duct stones., (© 2023 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
43. Immunohistochemical FAP Expression Reflects 68 Ga-FAPI PET Imaging Properties of Low- and High-Grade Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma.
- Author
-
Spektor AM, Gutjahr E, Lang M, Glatting FM, Hackert T, Pausch T, Tjaden C, Schreckenberger M, Haberkorn U, and Röhrich M
- Subjects
- Humans, Gallium Radioisotopes, Positron Emission Tomography Computed Tomography, Pancreatic Ducts metabolism, Pancreatic Ducts pathology, Positron-Emission Tomography, Pancreatic Intraductal Neoplasms diagnostic imaging, Pancreatic Intraductal Neoplasms pathology, Adenocarcinoma, Mucinous diagnosis, Adenocarcinoma, Mucinous pathology, Adenocarcinoma, Mucinous surgery, Pancreatic Neoplasms metabolism, Carcinoma, Pancreatic Ductal diagnostic imaging, Carcinoma, Pancreatic Ductal metabolism
- Abstract
Pancreatic intraductal papillary mucinous neoplasms (IPMNs) are grossly visible (typically > 5 mm) intraductal epithelial neoplasms of mucin-producing cells, arising in the main pancreatic duct or its branches. According to the current 2-tiered grading scheme, these lesions are categorized as having either low-grade (LG) dysplasia, which has a benign prognosis, or high-grade (HG) dysplasia, which formally represents a carcinoma in situ and thus can transform to pancreatic ductal adenocarcinoma (PDAC). Because both entities require different treatments according to their risk of becoming malignant, a precise pretherapeutic diagnostic differentiation is inevitable for adequate patient management. Recently, our group has demonstrated that
68 Ga-fibroblast activation protein (FAP) inhibitor (FAPI) PET/CT shows great potential for the differentiation of LG IPMNs, HG IPMNs, and PDAC according to marked differences in signal intensity and tracer dynamics. The purpose of this study was to biologically validate FAP as a target for PET imaging by analyzing immunohistochemical FAP expression in LG IPMNs, HG IPMNs, and PDAC and comparing with SUV and time to peak (TTP) measured in our prior study. Methods: To evaluate the correlation of the expression level of FAP and α-smooth muscle actin (αSMA) in neoplasm-associated stroma depending on the degree of dysplasia in IPMNs, 98 patients with a diagnosis of LG IPMN, HG IPMN, PDAC with associated HG IPMN, or PDAC who underwent pancreatic surgery at the University Hospital Heidelberg between 2017 and 2023 were identified using the database of the Institute of Pathology, University Hospital Heidelberg. In a reevaluation of hematoxylin- and eosin-stained tissue sections of formalin-fixed and paraffin-embedded resection material from the archive, which was originally generated for histopathologic routine diagnostics, a regrading of IPMNs was performed by a pathologist according to the current 2-tiered grading scheme, consequently eliminating the former diagnosis of "IPMN with intermediate-grade dysplasia." For each case, semithin tissue sections of 3 paraffin blocks containing neoplasm were immunohistologically stained with antibodies directed against FAP and αSMA. In a masked approach, a semiquantitative analysis of the immunohistochemically stained slides was finally performed by a pathologist by adapting the immunoreactive score (IRS) and human epidermal growth factor receptor 2 (Her2)/neu score to determine the intensity and percentage of FAP- and αSMA-positive cells. Afterward, the IRS of 14 patients who underwent68 Ga-FAPI-74 PET/CT in our previous study was compared with their SUVmax , SUVmean , and TTP for result validation. Results: From 98 patients, 294 specimens (3 replicates per patient) were immunohistochemically stained for FAP and αSMA. Twenty-three patients had LG IPMNs, 11 had HG IPMNs, 10 had HG IPMNs plus PDAC, and 54 had PDAC. The tumor stroma was in all cases variably positive for FAP. The staining intensity, percentage of FAP-positive stroma, IRS, and Her2/neu score increased with higher malignancy. αSMA expression could be shown in normal pancreatic stroma as well as within peri- and intraneoplastic desmoplastic reaction. No homogeneous increase in intensity, percentage, IRS, and Her2/neu score with higher malignancy was observed for αSMA. The comparison of the mean IRS of FAP with the mean SUVmax , SUVmean , and TTP of68 Ga-GAPI-74 PET/CT showed a matching value increasing with higher malignancy in68 Ga-FAPI-74 PET imaging and immunohistochemical FAP expression. Conclusion: The immunohistochemical staining of IPMNs and PDAC validates FAP as a biology-based stromal target for in vivo imaging. Increasing expression of FAP in lesions with a higher degree of malignancy matches the expectation of a stronger FAP expression in PDAC and HG IPMNs than in LG IPMNs and corroborates our previous findings of higher SUVs and a longer TTP in PDAC and HG IPMNs than in LG IPMNs., (© 2024 by the Society of Nuclear Medicine and Molecular Imaging.)- Published
- 2024
- Full Text
- View/download PDF
44. Mucosal damage in pancreaticobiliary maljunction is stronger in the gallbladder than in the bile duct.
- Author
-
Kamakura M, Uehara T, Muraki T, Iwaya M, Asaka S, Nakajima T, Iwaya Y, Nagaya T, Yoshizawa T, Shimizu A, Kuraishi Y, Ota H, and Umemura T
- Subjects
- Humans, Pancreatic Ducts pathology, Bile Ducts, Mucous Membrane pathology, Carcinogenesis metabolism, Pancreaticobiliary Maljunction metabolism, Gallbladder Neoplasms pathology
- Abstract
Background: The frequency of gallbladder carcinoma is high in pancreaticobiliary maljunction (PBM), and the mechanism of carcinogenesis is not well understood., Methods: The expression of γH2AX, the most sensitive marker for detecting DNA damage, was analyzed using immunohistochemistry in patients with PBM, in which the gallbladder and bile duct were simultaneously resected. Gallbladder and bile ducts were evaluated in non-neoplastic regions in 13 cases of PBM without cancer in the gallbladder and bile ducts., Results: The median frequencies of γH2AX expression in the bile duct and gallbladder within the same case were 5.9% (range 1.7-12.05%) and 9.9% (range 2.8-25%), respectively, and were significantly higher in the gallbladder mucosa (P < 0.0004). γH2AX expression strongly correlated in the bile duct and gallbladder (r = 0.9436, P < 0.0001). PBM caused marked mucosal damage to the gallbladder., Conclusions: Mucosal damage may be involved in carcinogenesis, which may be useful for predicting malignant transformation., Competing Interests: Declaration of Competing Interest I declared on behalf of all authors that all authors have no conflicts of interest to declare., (Copyright © 2023 Elsevier GmbH. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
45. Magnetic resonance cholangiopancreatography using T2 preparation pulse: quantitative and qualitative analyses.
- Author
-
Ihara R, Oura D, Ichimura W, and Kobayashi K
- Subjects
- Humans, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Liver, Signal-To-Noise Ratio, Imaging, Three-Dimensional methods, Cholangiopancreatography, Magnetic Resonance methods, Pancreatic Diseases pathology
- Abstract
Background: Magnetic resonance cholangiopancreatography (MRCP) may exhibit ghosting and blurring artifacts due to irregular breathing cycles, which can be overcome by shortening the shot duration. T2 preparation pulse enables heavy T2 contrast even with a shorter TE by use of the shortened shot duration; therefore, a technique using T2 preparation pulse combined with 3D turbo spin-echo MRCP (TPT-MRCP) was constructed., Purpose: To evaluate the clinical usefulness of TPT-MRCP in both navigation and breath-hold sequences compared to the conventional method., Material and Methods: We obtained navigation MRCP, which were TPT and conventional 3D turbo spin-echo in 37 patients, and breath-hold MRCP in 31 patients, which were TPT and gradient and spin echo. The quantitative evaluation included signal-to-noise ratio, contrast ratio, contrast-to-noise ratio and sharpness of the common bile duct in all sequences. Two radiologists visually evaluated image quality using a five-point grading method, assessing overall image quality and each of the six areas: common bile duct, right hepatic duct, left hepatic duct, main pancreatic duct, cystic duct and motion artifact., Results: TPT-MRCP was significantly superior to conventional MRCP in all quantitative evaluations, except for signal-to-noise ratio in the navigation sequence. In the visual evaluation, TPT-MRCP provided higher image quality than the conventional technique in nearly all areas. The kappa (k) coefficient of the overall image quality was good for all sequences (κ = 0.61-0.8)., Conclusion: TPT-MRCP provides higher image quality than conventional techniques in both navigation and breath-hold sequences. The present study demonstrates the greater clinical usefulness of TPT-MRCP., Competing Interests: Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2023
- Full Text
- View/download PDF
46. The role of abdominal ultrasonography in patients with isoattenuating pancreatic carcinoma.
- Author
-
Psar R, Urban O, Rohan T, Stepan M, Hill M, and Cerna M
- Subjects
- Humans, Retrospective Studies, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Ultrasonography, Tomography, X-Ray Computed, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms pathology
- Abstract
Aims: The main objective of this study was to determine the sensitivity of abdominal ultrasonography (US) in patients with isoattenuating pancreatic carcinoma and to compare the frequency of secondary signs on abdominal US and endoscopic ultrasonography (EUS) in these tumours., Methods: Twenty-four patients with histologically or cytologically verified isoattenuating pancreatic carcinoma who underwent abdominal US, contrast-enhanced CT and EUS of the pancreas as part of the diagnostic workup were included in this retrospective study. The sensitivity of abdominal US in detecting the isoattenuating pancreatic carcinoma was investigated and the frequency of secondary signs of isoattenuating pancreatic carcinoma on abdominal US and EUS was compared., Results: In 5 of 24 patients (21%) with isoattenuating pancreatic carcinoma, a hypoechogenic pancreatic lesion was directly visualised on abdominal US. Secondary signs were present on US in 21 patients (88%). These included dilatation of the common bile duct and/or intrahepatic bile ducts in 19/24 (79%), dilatation of the pancreatic duct in 3/24 (13%), abnormal contour/inhomogeneity of the pancreas in 1/24 (4%), and atrophy of the distal parenchyma in 1/24 (4%). Pancreatic duct dilatation was observed more frequently on EUS than on abdominal US (P=0.002). For other secondary signs, there was no significant difference in their detection on abdominal US and EUS (P=0.61-1.00)., Conclusion: Abdominal US is capable of detecting secondary signs of isoattenuating pancreatic carcinoma with high sensitivity and has the potential to directly visualise these tumours., Competing Interests: The authors report no conflicts of interest in this work.
- Published
- 2023
- Full Text
- View/download PDF
47. The accidental discovery of pancreatic ductal adenocarcinoma on percutaneous cholangioscopy through a T-tube tract.
- Author
-
Zhang W, Chai N, Zhai Y, Li H, Liu S, Gao F, and Linghu E
- Subjects
- Humans, Pancreatic Ducts pathology, Pancreatic Neoplasms, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms pathology, Carcinoma, Pancreatic Ductal diagnostic imaging, Carcinoma, Pancreatic Ductal surgery, Carcinoma, Pancreatic Ductal pathology
- Abstract
Competing Interests: The authors declare that they have no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
48. [An Intraductal Papillary Mucinous Neoplasm of the Pancreas with Metachronous Quadruple Cancers].
- Author
-
Ueda A, Matsuo Y, Yamamoto S, Kusudo N, Ito T, Murase H, Kato T, Imafuji H, Saito K, Morimoto M, Ogawa R, Takahashi H, Mitsui A, Kimura M, and Takiguch S
- Subjects
- Female, Humans, Pancreatectomy, Neoplasm Recurrence, Local surgery, Pancreatic Ducts pathology, Carcinoma, Pancreatic Ductal pathology, Pancreatic Intraductal Neoplasms surgery, Adenocarcinoma, Mucinous surgery, Adenocarcinoma, Mucinous diagnosis, Pancreatic Neoplasms pathology
- Abstract
The patient described herein was diagnosed with left breast, endometrial, and early gastric cancers at 49, 53, and 57 years of age, respectively. Magnetic resonance cholangiopancreatography performed when she was undergoing treatment for cholecystitis at 50 years of age showed local pancreatic duct dilatation in the pancreatic head. She was followed in the Department of Gastroenterology at our hospital for an intraductal papillary mucinous neoplasm(IPMN). An abdominal computed tomography scan obtained at 59 years of age revealed dilation of the main pancreatic duct in the pancreas body and tail, therefore an endoscopic ultrasound-guided fine needle aspiration was performed. She was diagnosed with pancreatic cancer and underwent a laparoscopic distal pancreatectomy. The postoperative course was uneventful; however, the pancreatic cancer recurred and she died approximately 14 months postoperatively. Reports of multiple cancers associated with IPMNs are rare, yet we managed a patient with a pancreatic head IPMN complicated by metachronous quadruple carcinomas( breast, endometrial, gastric, and pancreatic cancers).
- Published
- 2023
49. Branch-duct Intraductal Papillary Mucinous Neoplasm with Rapidly Developing Intracystic Xanthogranulomatous Nodules.
- Author
-
Kitagawa S, Ichihara S, Omori Y, Maeda C, Ono Y, Tahara M, Furukawa T, Muraoka S, and Miyakawa H
- Subjects
- Male, Humans, Aged, Pancreatic Ducts pathology, Carcinoma, Pancreatic Ductal complications, Carcinoma, Pancreatic Ductal surgery, Carcinoma, Pancreatic Ductal pathology, Pancreatic Intraductal Neoplasms pathology, Pancreatic Neoplasms complications, Pancreatic Neoplasms diagnosis, Pancreatic Neoplasms surgery, Cysts
- Abstract
We herein report a case of a branch-duct intraductal papillary mucinous neoplasm (IPMN) with rapidly developing intracystic xanthogranulomatous nodules. A unilocular cystic lesion without a mural nodule was found in the pancreatic tail of a 69-year-old man. Ten months later, multiple mural nodules emerged unexpectedly within the cyst, and the patient underwent distal pancreatectomy. Based on immunohistochemical studies and a molecular analysis, we diagnosed him with branch-duct IPMN of the gastric immunophenotype. Fragility of the pancreatic duct mucosa and consequent exposure of the wall to pancreatic juice might have caused marked granulation nodule formation in the cyst lumen.
- Published
- 2023
- Full Text
- View/download PDF
50. Enhancing Mural Nodules in the Main Pancreatic Duct of Main and Mixed Types of Intraductal Papillary Mucinous Neoplasms: Does Size Matter in Malignancy Risk?
- Author
-
Chon HK, Song TJ, Yoo KH, Hwang JS, Kim MH, Choi EK, and Kim TH
- Subjects
- Humans, Retrospective Studies, Pancreatic Ducts diagnostic imaging, Pancreatic Ducts pathology, Carcinoma, Pancreatic Ductal diagnostic imaging, Carcinoma, Pancreatic Ductal surgery, Carcinoma, Pancreatic Ductal pathology, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms surgery, Pancreatic Neoplasms pathology, Neoplasms, Cystic, Mucinous, and Serous pathology
- Abstract
Background/aims: Most guidelines recommend surgical resection of all main duct (MD) and mixed-type (MT) intraductal papillary mucinous neoplasms (IPMNs) in suitable patients. However, there is little evidence regarding the malignancy risk of enhancing mural nodules (EMNs) that are present only in the main pancreatic duct (MPD) in patients with MD- and MT-IPMNs. Therefore, this study aimed to identify the clinical and morphological features associated with malignancy in MD- and MT-IPMNs with EMNs only in the MPD., Methods: We retrospectively enrolled 50 patients with MD- and MT-IPMNs with EMNs only in the MPD on contrast-enhanced magnetic resonance imaging. We evaluated the clinical characteristics and preoperative radiologic imaging results of MPD morphology and EMN size and analyzed the risk factors associated with malignancy., Results: Histological findings of EMNs were low-grade dysplasia (38%), malignant lesions (62%), high-grade dysplasia (34%), and invasive carcinoma (28%). On the receiver operating characteristic curve, the cutoff value of EMN size on magnetic resonance imaging for best predicting malignancy was 5 mm (sensitivity, 93.5%; specificity, 52.6%; area under the curve, 0.753). Multivariate analysis showed that only EMN >5 mm (odds ratio, 27.69; confidence interval, 2.75 to 278.73; p=0.050) was an independent risk factor for malignancy., Conclusions: EMNs of >5 mm are associated with malignancy in patients with MD- and MT-IPMNs with EMNs that are present only in the MPD, in accordance with the international consensus guidelines.
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.